Katiuscia Nan Selected Research

Adalimumab (Humira)

1/2020

Adalimumab-associated spondylodiscitis: A new or underestimated side effect?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katiuscia Nan Research Topics

Disease

1	Inflammation (Inflammations) 05/2022
1	Atopic Dermatitis (Atopic Eczema) 05/2022
1	Prurigo 05/2022
1	Cutaneous Lupus Erythematosus 01/2020
1	Discitis 01/2020
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 04/2018
1	Shoulder Injuries 12/2017
1	Disease Progression 01/2015
1	Borrelia Infections 01/2015

Drug/Important Bio-Agent (IBA)

1	dupilumabIBA 05/2022
1	Interleukin-4 Receptor alpha SubunitIBA 05/2022
1	Interleukin-13IBA 05/2022
1	CytokinesIBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	InterleukinsIBA 05/2022
1	secukinumabIBA 01/2020
1	Adalimumab (Humira)FDA Link 01/2020
1	Immunoglobulin M (IgM)IBA 01/2015
1	AntibodiesIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015

Therapy/Procedure

1	Semiconductor Lasers 04/2018
1	Bandages (Bandage) 12/2017
1	Aftercare (After-Treatment) 01/2015
1	Therapeutics 01/2015